Most Recent
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
Hino Motors has agreed to pay $87 million to settle a consumer class action alleging it misrepresented that its vehicles met Australian emissions and road standards over a 20-year period.
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
A judge has approved a $56 million settlement in a class action alleging Monash IVF destroyed potentially viable embryos, including a $10.6 million payout for the firm that ran the case.
Johnson & Johnson has been hit with a class action for allegedly pushing ineffective cold and flu medications containing phenylephrine onto customers for decades.
A class action against Toyota Finance has argued it can add new claims that are out of time because Victorian courts cannot factor in the loss of limitations defences in deciding whether to allow amendments.
Graincorp may face new allegations in a class action that the use of n-Hexane at an oilseed factory in rural Victoria had an impact on the health of local residents.
A judge has given the green light to a $31.5 million settlement in a class action brought by junior doctors accusing the ACT government and North Canberra Hospital of failing to pay overtime.
A judge has approved a $57.5 million settlement in a class action against ANZ over credit card interest, including allowing the funder to recoup $1.2 million in after-the-event insurance costs.